The world of rare interstitial lung diseases (ILDs) is diverse and complex. Diagnosis and
therapy usually pose challenges. This review describes a selection of rare and ultrarare ILDs …

Having sarcoidosis often has a major impact on quality of life of patients and their families.
Improving quality of life is prioritized as most important treatment aim by many patients with …

Background Interstitial lung diseases (ILD) comprise a heterogeneous group of mainly chronic
lung diseases with different disease trajectories. Progression (PF-ILD) occurs in up to 50…

Background Interstitial lung diseases (ILD) comprise a heterogeneous group of mainly chronic
lung diseases with more than 200 entities and relevant differences in disease course and …

Background: Sarcoidosis is a multisystemic disease with a heterogenous course of disease.
Comprehensive information about the complexity and treatment indications is essential for …

Introduction Conservative management is usually preferred for iatrogenic tracheal injuries.
Venovenous extracorporeal membrane oxygenation (VV ECMO) is mostly used in acute …

Background – Sarcoidosis is a multisystemic disease with a heterogenous course of disease.
Comprehensive information about the complexity of the disease and treatment decisions …

Introduction Many patients use the internet as a source of health information. Sarcoidosis is
a complex disease, and internet resources have not yet been analyzed for reliability and …

Background The clinical and molecular characteristics of three patients with previously
unreported SERPINA1 mutations associated with severe alpha-1 antitrypsin deficiency (AATD) …

The present recommendations on the therapy of sarcoidosis of the German Respiratory
Society (DGP) was written in 2023 as a German-language supplement and update of the …